RxDoctor Payments Data

Brian Deutsch, MD

Otolaryngology/Facial Plastic Surgery · Norfolk, VANPI 1881695252

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,997 of the $2,370 with a category attached, or 84.3%. It is spread thinly across 15 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,021, 6.7 times the $153 reported in 2019.

$2,370in general payments, 2019–2025

Across 62 payments — averaging $38.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$488
  • Regeneron Healthcare Solutions, Inc.$364
  • GSK$344
  • Medtronic$218
  • Integra Lifesciences Corporation$203
  • Aerin Medical Inc.$165
  • plus $587 from 9 others

What the payments were for

  • Travel & lodging$37316%
  • Food & beverage$1,99784%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otolaryngology/facial plastic surgery providers in Virginiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$191,238
Medicare patients
528
Services billed
1,787

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth14$1,601
Fluocinolone Acetonide Oil26$1,050
Azelastine Hcl50$672
Ipratropium Bromide22$424
Cephalexin65$394
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen34$150
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim12$26

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Norfolk

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →